Pipeline
As of Oct. 25, 2020
State of New Product Development[PDF: 88.3 KB]
Disease Area:
- * Asia:excluding Japan and China
Disease Area | Development code | Indications |
Stage
123Filed
|
Region |
Immuno-inflammation
MT-5547
Osteoarthritis
Japan
- Generic name
- Fasinumab
- Category(Indications)
- Fully human anti-NGF monoclonal antibody(Osteoarthritis)
- Origin/licensee
- Licensed from Regeneron(US)
Immuno-inflammation
MT-7117
Erythropoietic protoporphyria, X-Linked protoporphyria
Global
- Generic name
- Dersimelagon
- Category(Indications)
- Selective melanocortin 1 receptor agonist(Erythropoietic protoporphyria, X-Linked protoporphyria)
- Origin/licensee
- In-house
Immuno-inflammation
MT-1303
Multiple sclerosis
Europe
- Generic name
- Amiselimod
- Category(Indications)
- S1P receptor functional antagonist(Multiple sclerosis)
- Origin/licensee
- In-house
Immuno-inflammation
MT-1303
Crohn's disease
Japan
- Generic name
- Amiselimod
- Category(Indications)
- S1P receptor functional antagonist(Crohn's disease)
- Origin/licensee
- In-house
Immuno-inflammation
MT-2990
Endometriosis
Global
- Category(Indications)
- Fully human anti-interleukin-33 (IL-33) monoclonal antibody(Endometriosis)
- Origin/licensee
- In-house
Diabetes and kidney
TA-7284
Diabetic nephropathy
Asia
- Product name
- Canaglu/INVOKANA
- Generic name
- Canagliflozin
- Category(Indications)
- SGLT2 inhibitor(Diabetic nephropathy)
- Origin/licensee
- In-house
Diabetes and kidney
TA-7284
Diabetic nephropathy
Japan
- Product name
- Canaglu/INVOKANA
- Generic name
- Canagliflozin
- Category(Indications)
- SGLT2 inhibitor(Diabetic nephropathy)
- Origin/licensee
- In-house
Diabetes and kidney
MP-513
Type 2 diabetes mellitus
Asia
- Product name
- Tenelia
- Generic name
- Teneligliptin
- Category(Indications)
- DPP-4 inhibitor(Type 2 diabetes mellitus)
- Origin/licensee
- In-house
Diabetes and kidney
MP-513
Type 2 diabetes mellitus
China
- Product name
- Tenelia
- Generic name
- Teneligliptin
- Category(Indications)
- DPP-4 inhibitor(Type 2 diabetes mellitus)
- Origin/licensee
- In-house
Diabetes and kidney
MP-513
Type 2 diabetes mellitus
Europe
- Product name
- Tenelia
- Generic name
- Teneligliptin
- Category(Indications)
- DPP-4 inhibitor(Type 2 diabetes mellitus)
- Origin/licensee
- In-house
Diabetes and kidney
MT-3995
Diabetic nephropathy
Europe
- Generic name
- Apararenone
- Category(Indications)
- Selective mineralocorticoid receptor antagonist(Diabetic nephropathy)
- Origin/licensee
- In-house
Diabetes and kidney
MT-3995
Diabetic nephropathy
Japan
- Generic name
- Apararenone
- Category(Indications)
- Selective mineralocorticoid receptor antagonist(Diabetic nephropathy)
- Origin/licensee
- In-house
Diabetes and kidney
MT-3995
Non-alcoholic steatohepatitis: NASH
Japan
- Generic name
- Apararenone
- Category(Indications)
- Selective mineralocorticoid receptor antagonist(Non-alcoholic steatohepatitis: NASH)
- Origin/licensee
- In-house
Central nervous system
MCI-186
Amyotrophic lateral sclerosis: ALS
Asia
- Product name
- Radicut/Radicava
- Generic name
- Edaravone
- Category(Indications)
- Free radical scavenger(Amyotrophic lateral sclerosis: ALS)
- Origin/licensee
- In-house
Central nervous system
MP-214
Schizophrenia
Asia
- Generic name
- Cariprazine
- Category(Indications)
- Dopamine D3/D2 receptor partial agonist(Schizophrenia)
- Origin/licensee
- Licensed from Gedeon Richter (Hungary)
Central nervous system
MT-0551
Neuromyelitis optica spectrum disorder:NMOSD
Japan
- Generic name
- Inebilizumab
- Category(Indications)
- Humanized anti-CD19 monoclonal antibody(Neuromyelitis optica spectrum disorder:NMOSD)
- Origin/licensee
- Licensed from Viela Bio (US)
Central nervous system
MT-0551
Neuromyelitis optica spectrum disorder:NMOSD
Asia
- Generic name
- Inebilizumab
- Category(Indications)
- Humanized anti-CD19 monoclonal antibody(Neuromyelitis optica spectrum disorder:NMOSD)
- Origin/licensee
- Licensed from Viela Bio (US)
Central nervous system
MT-210
Schizophrenia
US,Europe
- Generic name
- Roluperidone
- Category(Indications)
- 5-HT2A/Sigma 2 receptor antagonist(Schizophrenia)
- Origin/licensee
- Licensed to Minerva Neurosciences (US)
Central nervous system
MT-5199
Tardive dyskinesia
Japan
- Generic name
- Valbenazine
- Category(Indications)
- Vesicular monoamine transporter type 2 inhibitor(Tardive dyskinesia)
- Origin/licensee
- Licensed from Neurocrine Biosciences (US)
Central nervous system
MT-5199
Tardive dyskinesia
Asia
- Generic name
- Valbenazine
- Category(Indications)
- Vesicular monoamine transporter type 2 inhibitor(Tardive dyskinesia)
- Origin/licensee
- Licensed from Neurocrine Biosciences (US)
Central nervous system
ND0612
Parkinson's disease
Global
- Generic name
- Levodopa/Carbidopa
- Category(Indications)
- Continuous SC pump(Parkinson's disease)
- Origin/licensee
- In-house
Central nervous system
MT-1186
Amyotrophic lateral sclerosis: ALS / Oral suspension
Global
- Generic name
- Edaravone
- Category(Indications)
- Free radical scavenger(Amyotrophic lateral sclerosis: ALS / Oral suspension)
- Origin/licensee
- In-house
Central nervous system
MT-8554
Painful diabetic peripheral neuropathy
Europe
- Generic name
- Elismetrep
- Category(Indications)
- TRPM8 antagonist(Painful diabetic peripheral neuropathy)
- Origin/licensee
- In-house
Central nervous system
MT-8554
Vasomotor symptoms associated with menopause
Global
- Generic name
- Elismetrep
- Category(Indications)
- TRPM8 antagonist(Vasomotor symptoms associated with menopause)
- Origin/licensee
- In-house
Central nervous system
MT-3921
Spinal cord injury
- Category(Indications)
- Anti-RGMa antibody(Spinal cord injury)
- Origin/licensee
- Co-developed with Osaka University (Japan)
Vaccines
MT-2355
Prophylaxis of pertussis, diphtheria, tetanus, poliomyelitis and prophylaxis of Hib infection in infants
Japan
- Category(Indications)
- Combined vaccine(Prophylaxis of pertussis, diphtheria, tetanus, poliomyelitis and prophylaxis of Hib infection in infants)
- Origin/licensee
- Co-developed with The Research Foundation for Microbial Diseases of Osaka University (Japan)
Vaccines
MT-2271
Prophylaxis of seasonal influenza/adults
Canada
- Category(Indications)
- Plant-based VLP vaccine(Prophylaxis of seasonal influenza/adults)
- Origin/licensee
- Medicago product (Canada)
Vaccines
MT-2271
Prophylaxis of seasonal influenza/adults
Europe
- Category(Indications)
- Plant-based VLP vaccine(Prophylaxis of seasonal influenza/adults)
- Origin/licensee
- Medicago product (Canada)
Vaccines
MT-2271
Prophylaxis of seasonal influenza/elderly
Europe
- Category(Indications)
- Plant-based VLP vaccine(Prophylaxis of seasonal influenza/elderly)
- Origin/licensee
- Medicago product (Canada)
Vaccines
MT-8972
Prophylaxis of H5N1 influenza
Canada
- Category(Indications)
- Plant-based VLP vaccine(Prophylaxis of H5N1 influenza)
- Origin/licensee
- Medicago product (Canada)
Vaccines
MT-7529
Prophylaxis of H7N9 influenza
- Category(Indications)
- Plant-based VLP vaccine(Prophylaxis of H7N9 influenza)
- Origin/licensee
- Medicago product (Canada)
Vaccines
MT-5625
Prophylaxis of rotavirus gastroenteritis
- Category(Indications)
- Plant-based VLP vaccine(Prophylaxis of rotavirus gastroenteritis)
- Origin/licensee
- Medicago product (Canada)
Vaccines
MT-2766
Prophylaxis of COVID-19
- Category(Indications)
- Plant-based VLP vaccine(Prophylaxis of COVID-19)
- Origin/licensee
- Medicago product (Canada)
Others
MT-4580
Secondary Hyperparathyroidism
China,Asia
- Product name
- Orkedia
- Generic name
- Evocalcet
- Category(Indications)
- Ca sensing receptor agonist(Secondary Hyperparathyroidism)
- Origin/licensee
- Licensed to Kyowa Kirin (Japan)
Others
MT-4129
- Category(Indications)
- Cardiovascular system, etc.
- Origin/licensee
- In-house
Others
MT-8633/ TR1801-ADC
Solid tumor
- Category(Indications)
- Anti-c-Met ADC(Solid tumor)
- Origin/licensee
- In-house / Collaborate with Open Innovation Partners (Japan)
There is no development status of the applicable area.
Please select one or more disease areas.
- * Asia:excluding Japan and China
Development code | Indications | Previous Announcement | As of Oct. 25, 2020 | ||
Stage
123FiledApproved
|
Region |
Stage
123FiledApproved
|
Region |
MP-214
Schizophrenia
Asia
Malaysia
- Generic name
- Cariprazine
- Category(Indications)
- Dopamine D3/D2 receptor partial agonist(Schizophrenia)
- Origin/licensee
- Licensed from Gedeon Richter (Hungary)
TA-7284
Type 2 diabetes mellitus
Asia
Indonesia
- Product name
- Canaglu/INVOKANA
- Generic name
- Canagliflozin
- Category(Indications)
- SGLT2 inhibitor(Type 2 diabetes mellitus)
- Origin/licensee
- In-house
MT-0551
Neuromyelitis optica spectrum disorder:NMOSD
Asia
Asia
- Generic name
- Inebilizumab
- Category(Indications)
- Humanized anti-CD19 monoclonal antibody(Neuromyelitis optica spectrum disorder:NMOSD)
- Origin/licensee
- Licensed from Viela Bio (US)
TAU-284
Allergic rhinitis, Urticaria
Asia
- Product name
- Talion
- Generic name
- Bepotastine
- Category(Indications)
- Selective histamine H1 receptor antagonist, anti-allergic agent(Allergic rhinitis, Urticaria)
- Origin/licensee
- Licensed from Ube Industries (Japan)
MT-2990
Seasonal Allergic Rhinitis
- Category(Indications)
- Fully human anti-interleukin-33 (IL-33) monoclonal antibody(Seasonal Allergic Rhinitis)
- Origin/licensee
- In-house